Results 191 to 200 of about 761 (228)

EC Private Antitrust Enforcement

2014
openaire   +1 more source

Private antitrust enforcement in Germany

Competition Law & Policy Debate, 2018
openaire   +1 more source

Measuring the value of public–private partnerships in the pharmaceutical sciences

Nature Reviews Drug Discovery, 2012
Daan J A Crommelin
exaly  

Private Enforcement of Antitrust

2014
openaire   +1 more source

What is the private sector? Understanding private provision in the health systems of low-income and middle-income countries

Lancet, The, 2016
Maureen Mackintosh, Anup Karan, Sakthivel Selvaraj   +2 more
exaly  

Public-private partnerships investment in energy as new determinant of CO2 emissions: The role of technological innovations in China

Energy Economics, 2020
Chandrashekar Raghutla, Hashim Zameer, Zhilun Jiao   +2 more
exaly  

Performance of private sector health care: implications for universal health coverage

Lancet, The, 2016
Rosemary Morgan, Timothy Ensor
exaly  

Virtual drug discovery and development for neglected diseases through public–private partnerships

Nature Reviews Drug Discovery, 2003
Solomon Nwaka
exaly  

Prohibit, constrain, encourage, or purchase: how should we engage with the private health-care sector?

Lancet, The, 2016
Dominic Montagu, Catherine A Goodman
exaly  

Private enforcement of antitrust damages in EU law

2016
The oldest objective of the European Union was to create an internal market. However, a healthy market requires competition, which encourages companies to be efficient, innovative, reduce prices and offer their products to the consumer at the most favourable terms. This can be achieved only if they act independently of each other.
openaire   +1 more source